John Kwan

781 total citations
33 papers, 508 citations indexed

About

John Kwan is a scholar working on Hematology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John Kwan has authored 33 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Oncology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John Kwan's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). John Kwan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). John Kwan collaborates with scholars based in Australia, United States and New Zealand. John Kwan's co-authors include Gillian Huang, Philippe Martiat, David Gottlieb, Philippe Lewalle, Dominique Bron, Kenneth F. Bradstock, Nathalie Meuleman, F. Crokaert, Imran Ahmad and Tatiana Tondreau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

John Kwan

30 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Kwan Australia 12 318 208 111 110 102 33 508
Simona Lapusan France 15 350 1.1× 271 1.3× 124 1.1× 109 1.0× 73 0.7× 33 676
Stephanie Farnia United States 13 356 1.1× 211 1.0× 187 1.7× 60 0.5× 160 1.6× 22 669
Gillian Huang Australia 10 193 0.6× 135 0.6× 80 0.7× 81 0.7× 110 1.1× 21 413
Michael Gratwohl Switzerland 8 398 1.3× 134 0.6× 144 1.3× 86 0.8× 85 0.8× 9 521
Meerim Park South Korea 16 191 0.6× 119 0.6× 77 0.7× 77 0.7× 66 0.6× 49 521
Maarten Egeler Netherlands 11 258 0.8× 145 0.7× 85 0.8× 95 0.9× 43 0.4× 29 769
Nada Hamad Australia 13 253 0.8× 235 1.1× 88 0.8× 98 0.9× 151 1.5× 93 560
Kyung‐Nam Koh South Korea 14 297 0.9× 151 0.7× 76 0.7× 166 1.5× 91 0.9× 89 660
S J Lee United States 12 322 1.0× 224 1.1× 163 1.5× 235 2.1× 60 0.6× 12 729
Minako Iida Japan 7 290 0.9× 102 0.5× 82 0.7× 105 1.0× 78 0.8× 13 436

Countries citing papers authored by John Kwan

Since Specialization
Citations

This map shows the geographic impact of John Kwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kwan more than expected).

Fields of papers citing papers by John Kwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kwan. The network helps show where John Kwan may publish in the future.

Co-authorship network of co-authors of John Kwan

This figure shows the co-authorship network connecting the top 25 collaborators of John Kwan. A scholar is included among the top collaborators of John Kwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Kwan. John Kwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yeung, David T, Laura N Eadie, Susan L. Heatley, et al.. (2024). Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol. PubMed. 2(1). 100041–100041. 1 indexed citations
3.
Kwan, John, Joshua Hoffman, Jeffrey A. Douglas, et al.. (2024). Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral allosteric TYK2 inhibitor ESK‐001 using a randomized, double‐blind, placebo‐controlled study design. Clinical and Translational Science. 17(12). e70094–e70094. 6 indexed citations
4.
5.
Moore, John J., Nada Hamad, David Gottlieb, et al.. (2023). Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study. Blood Advances. 7(18). 5554–5565. 3 indexed citations
6.
Kliman, David, Glen Kennedy, Cameron Curley, et al.. (2022). The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR. Bone Marrow Transplantation. 57(6). 982–989. 3 indexed citations
7.
8.
Nivison‐Smith, Ian, Samuel T. Milliken, Anthony J. Dodds, et al.. (2017). Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand. Biology of Blood and Marrow Transplantation. 24(1). 169–174. 3 indexed citations
9.
Gilroy, Nicole, Gemma Dyer, Md. Feroz Kabir, et al.. (2016). The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia. Bone Marrow Transplantation. 51(10). 1361–1368. 19 indexed citations
10.
Gilroy, Nicole, Gemma Dyer, Matthew Greenwood, et al.. (2016). Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?. Supportive Care in Cancer. 25(2). 421–427. 27 indexed citations
11.
Smith, Jennifer, Nicole Gilroy, Gemma Dyer, et al.. (2016). Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia. Supportive Care in Cancer. 25(1). 137–144. 8 indexed citations
12.
Patton, W. N., Ian Nivison‐Smith, Peter Bardy, et al.. (2016). Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry. Biology of Blood and Marrow Transplantation. 23(1). 147–152. 4 indexed citations
13.
Dyer, Gemma, Nicole Gilroy, Matthew Greenwood, et al.. (2015). What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia. Biology of Blood and Marrow Transplantation. 22(4). 731–743. 21 indexed citations
14.
15.
Bradstock, Kenneth F., Ian Bilmon, John Kwan, et al.. (2015). Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors. Biology of Blood and Marrow Transplantation. 21(9). 1641–1645. 29 indexed citations
16.
Raj, Kavita, Antonio Pagliuca, Kenneth F. Bradstock, et al.. (2014). Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning. Biology of Blood and Marrow Transplantation. 20(6). 890–895. 94 indexed citations
17.
Meuleman, Nathalie, Tatiana Tondreau, Imran Ahmad, et al.. (2009). Infusion of Mesenchymal Stromal Cells can Aid Hematopoietic Recovery Following Allogeneic Hematopoietic Stem Cell Myeloablative Transplant: A Pilot Study. Stem Cells and Development. 18(9). 1247–1252. 70 indexed citations
18.
Ahmad, Imran, John Kwan, Younes Maaroufi, et al.. (2009). Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation. Transplantation. 87(8). 1240–1245. 48 indexed citations
19.
Meuleman, Nathalie, Tatiana Tondreau, Philippe Lewalle, et al.. (2008). Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stromal Cell (MSC) infusion for the Treatment of Metachromatic Leukodystrophy (MLD): A case report. Haematologica. 93(1). 48. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Lapusan Breakdown of academic impact, for papers by Stephanie Farnia Breakdown of academic impact, for papers by Gillian Huang Breakdown of academic impact, for papers by Michael Gratwohl Breakdown of academic impact, for papers by Meerim Park Breakdown of academic impact, for papers by Maarten Egeler Breakdown of academic impact, for papers by Nada Hamad Breakdown of academic impact, for papers by Kyung‐Nam Koh Breakdown of academic impact, for papers by S J Lee Breakdown of academic impact, for papers by Minako Iida
Rankless by CCL
2026